Linden Advisors’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Linden Advisors’s Portfolio IQMDW Stock Details IQMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-275,648	Closed	-$13.2K	–	487
2023 Q1	$13.2K	Hold	275,648	–	–	﹤0.01%	414
2022 Q4	$7.14K	Hold	275,648	–	–	﹤0.01%	521
2022 Q3	$29K	Hold	275,648	–	–	﹤0.01%	567
2022 Q2	$39K	Hold	275,648	–	–	﹤0.01%	594
2022 Q1	$77K	Buy	+275,648	New	+$100K	﹤0.01%	611

Linden Advisors's IQMDW Position: Q2 2023 in Review

Linden Advisors sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 275,648 shares — an estimated $13.2K sold.

Linden Advisors first reported a position in IQMDW in Q1 2022 and held it in 5 quarters. The position peaked at $77K in Q1 2022. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

Linden Advisors reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Linden Advisors sold 275,648 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $13.2K.
Linden Advisors first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q1 2022 and held it in 5 quarters.
Linden Advisors's Intelligent Medicine Acquisition Corp. Warrant position peaked at $77K in Q1 2022.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Linden Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.